Core Laboratories Inc.
CLB
$11.18
$0.211.91%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.31% | -14.38% | -36.46% | -39.97% | 58.23% |
| Total Depreciation and Amortization | -4.85% | -5.26% | -5.13% | -4.99% | -6.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -121.91% | 95.64% | 347.04% | 787.86% | -104.32% |
| Change in Net Operating Assets | 183.57% | 127.38% | 118.03% | 80.01% | 48.47% |
| Cash from Operations | 71.76% | 127.47% | 197.25% | 70.07% | 102.99% |
| Capital Expenditure | -18.66% | -23.15% | -15.40% | -33.06% | -12.80% |
| Sale of Property, Plant, and Equipment | 137.78% | 257.94% | -46.95% | -52.42% | -47.14% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 73.74% | 42.30% | 5.59% | -37.77% | 147.70% |
| Cash from Investing | 36.77% | 3.88% | -67.76% | -252.96% | 0.81% |
| Total Debt Issued | -77.60% | -78.22% | -80.92% | -42.93% | 53.60% |
| Total Debt Repaid | 62.26% | 61.14% | 66.54% | 26.37% | -59.40% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -224.45% | -140.96% | -8.76% | -13.99% | -13.16% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.37% | -0.43% | -0.48% | -0.59% | -0.75% |
| Other Financing Activities | 95.57% | 85.58% | 57.05% | 42.44% | -9.47% |
| Cash from Financing | -62.16% | -149.16% | -259.38% | -244.40% | -79.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 624.34% | 1,410.71% | 68.45% | -184.62% | 76.15% |